TGFB1 and systemic lupus erythematosus: Therefore, because impairment in the TGF-β1 pathway has been associated with both an SLE-like illness and enhanced atherogenesis, we hypothesize that this pathway might represent a link between the inflammatory and atherosclerotic processes seen in SLE [11].